🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 09074M103 (prev. 41690A106 )
- Market Cap
- Micro Cap · $26 Million
- Previous Symbol
- HART (changed 4/1/2016)
- Previous Name
- Harvard Apparatus Regenerative Technology, Inc.
Business: Biostage, Inc. is a biotechnology company engaged in developing regenerative medicine, stem cell therapy and tissue engineering. The Company develops bioengineered organ implants based on its Cellframe technology. Its pipeline includes Cellspan Esophageal Implants, Cellspan Bronchial Implants, Cellspan Tracheal Implants and Cellspan Pediatric Esophageal Implants. These implants are being developed to treat life-threatening conditions of the esophageal, bronchial and tracheal cancers, trauma and congenital abnormalities.
Company Contact
- CEO
- James J. McGorry
- CFO
- Thomas McNaughton
- Headquarters
- 84 October Hill Road, Holliston, MA 01746
- Phone
- 774-233-7300 · Toll-Free 855-209-3104
- Fax
- 774-233-7302
- Investor Relations
- Catalyst Global · 212-924-9800 · bstg@catalyst-ir.com